Distinguished in Secondary Immunodeficiency (SID)

Dr. Daniel T. Layish

Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine
Central Florida Pulmonary Group
610 Jasmine Road, 
Altamonte Springs, FL 
Accepting New Patients
Offers Telehealth
Distinguished in Secondary Immunodeficiency (SID)
Central Florida Pulmonary Group
610 Jasmine Road, 
Altamonte Springs, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Daniel Layish is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Altamonte Springs, Florida. Dr. Layish is rated as a Distinguished provider by MediFind in the treatment of Secondary Immunodeficiency (SID). His top areas of expertise are Cystic Fibrosis, Lung Metastases, Pneumonia, Secondary Immunodeficiency (SID), and Gastrostomy. Dr. Layish is currently accepting new patients.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pulmonary Medicine
Intensive Care Medicine
Sleep Medicine
Licenses
Internal Medicine in FL
Hospital Affiliations
Adventhealth Orlando
Orlando Health
Languages Spoken
English
Hebrew
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Florida Blue
  • EPO
  • PPO
Freedom Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Health Options
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 24 Less Insurance Carriers -

Locations

Central Florida Pulmonary Group
610 Jasmine Road, Altamonte Springs, FL 32701
Other Locations
Central Florida Pulmonary Group
1115 East Ridgewood Street, Orlando, FL 32803

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Active_not_recruiting
Publish Date: June 24, 2025
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
Enrollment Status: Completed
Publish Date: January 18, 2023
Intervention Type: Drug, Other
Study Drug: Lenabasum
Study Phase: Phase 2
An Open-label, Non-controlled, Multicenter, Pilot Trial, Using Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial (NTM) Infection
An Open-label, Non-controlled, Multicenter, Pilot Trial, Using Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial (NTM) Infection
Enrollment Status: Terminated
Publish Date: January 10, 2023
Intervention Type: Device, Drug
Study Phase: Phase 2
A Phase III, Randomized, Double-blind, Placebo-controlled Study of AeroVanc for the Treatment of Persistent Methicillin-resistant Staphylococcus Aureus Lung Infection in Cystic Fibrosis Patients
A Phase III, Randomized, Double-blind, Placebo-controlled Study of AeroVanc for the Treatment of Persistent Methicillin-resistant Staphylococcus Aureus Lung Infection in Cystic Fibrosis Patients
Enrollment Status: Completed
Publish Date: December 16, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of VX-814 in PiZZ Subjects
A Phase 2, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of VX-814 in PiZZ Subjects
Enrollment Status: Terminated
Publish Date: February 02, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Investigating the Optimal Dose Regimen, Efficacy, and Safety of Adding Oral Cysteamine in Adult Patients Being Treated for an Exacerbation of CF-associated Lung Disease
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Investigating the Optimal Dose Regimen, Efficacy, and Safety of Adding Oral Cysteamine in Adult Patients Being Treated for an Exacerbation of CF-associated Lung Disease
Enrollment Status: Completed
Publish Date: April 14, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 Administered Orally Once-Daily for 48 Weeks in Adult Patients With Cystic Fibrosis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 Administered Orally Once-Daily for 48 Weeks in Adult Patients With Cystic Fibrosis
Enrollment Status: Completed
Publish Date: September 04, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

1 Total Publications

Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial.
Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial.
Journal: PloS one
Published: July 10, 2020
Similar Doctors
Advanced in Secondary Immunodeficiency (SID)
Dr. Francisco J. Calimano
Pulmonary Medicine | Intensive Care Medicine
Advanced in Secondary Immunodeficiency (SID)
Dr. Francisco J. Calimano
Pulmonary Medicine | Intensive Care Medicine

Central Florida Pulmonary Group

610 Jasmine Road, 
Altamonte Springs, FL 
 (8.2 miles away)
407-841-1100
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Francisco Calimano is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Altamonte Springs, Florida. Dr. Calimano is rated as an Advanced provider by MediFind in the treatment of Secondary Immunodeficiency (SID). His top areas of expertise are Asthma in Children, Asthma, Lung Metastases, and Chronic Obstructive Pulmonary Disease (COPD). Dr. Calimano is currently accepting new patients.

Experienced in Secondary Immunodeficiency (SID)
Dr. Chetna R. Jinjuvadia
Pulmonary Medicine | Intensive Care Medicine
Experienced in Secondary Immunodeficiency (SID)
Dr. Chetna R. Jinjuvadia
Pulmonary Medicine | Intensive Care Medicine

Halifax Healthcare Systems Inc

3400 E Halifax Crossing Blvd, Suite 120a, 
Deltona, FL 
 (28.9 miles away)
386-425-6810
Languages Spoken:
English, Hindi, Punjabi
See accepted insurances
Accepting New Patients
Offers Telehealth

Chetna Jinjuvadia is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Deltona, Florida. Dr. Jinjuvadia is rated as an Advanced provider by MediFind in the treatment of Secondary Immunodeficiency (SID). Her top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Gastrostomy. Dr. Jinjuvadia is currently accepting new patients.

Experienced in Secondary Immunodeficiency (SID)
Dr. Hadi S. Chohan
Pulmonary Medicine | Intensive Care Medicine
Experienced in Secondary Immunodeficiency (SID)
Dr. Hadi S. Chohan
Pulmonary Medicine | Intensive Care Medicine

Orlando Health Medical Group Inc

1222 S Orange Ave, 
Orlando, FL 
 (1.5 miles away)
407-650-1300
Experience:
17+ years
Languages Spoken:
English, Arabic, Hebrew, Hindi, Italian, Spanish, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Hadi Chohan is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Orlando, Florida. Dr. Chohan has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Secondary Immunodeficiency (SID). His top areas of expertise are Lung Metastases, Pneumonia, COVID-19, Gastrostomy, and Bone Marrow Aspiration. Dr. Chohan is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Layish's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 27 Advanced Conditions
    View All 27 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile